Lenalidomide and dexamethasone with or without high-dose melphalan and autologous blood stem cell transplantation followed by lenalidomide maintenance in the treatment of relapsed multiple myeloma

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2010
This article has no abstract
Epistemonikos ID: 527a75dccf305fe71f2aa3ee3e1a038fc2239838
First added on: Jan 17, 2025